Mitogenic Properties of Endogenous and Pharmacological Doses of Macrophage Inflammatory Protein-2 after 70% Hepatectomy in the Mouse
- 31 August 2003
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 163 (2) , 563-570
- https://doi.org/10.1016/s0002-9440(10)63684-x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Chemokine Signaling and Functional Responses: The Role of Receptor Dimerization and TK Pathway ActivationAnnual Review of Immunology, 2001
- Inhibition of Signal Transducer and Activator Transcription Factor 3 in Rats with Acute Hepatic FailureBiochemical and Biophysical Research Communications, 2000
- Macrophage inflammatory protein-2 gene therapy attenuates adenovirus- and acetaminophen-mediated hepatic injuryGene Therapy, 1999
- Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: Requirement for type 1 but not type 2 receptorHepatology, 1998
- Liver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient MiceScience, 1996
- Acute-phase response factor, increased binding, and target gene transcription during liver regenerationGastroenterology, 1996
- Cytokine-induced neutrophil chemoattractant release from hepatocytes is modulated by Kupffer cellsHepatology, 1996
- Cytokine-induced neutrophil chemoattractant release from hepatocytes is modulated by Kupffer cellsHepatology, 1996
- Stat3: a STAT Family Member Activated by Tyrosine Phosphorylation in Response to Epidermal Growth Factor and Interleukin-6Science, 1994
- Properties of the Novel Proinflammatory Supergene "Intercrine" Cytokine FamilyAnnual Review of Immunology, 1991